Type 2 Diabetes and Bone Mineral Density: A Meta-analysis and Systematic Review

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Nov 13

PMID 39533557

Authors

Minghan Li

Hanqiao Sun

Honggu Chen

Weiwei Ma

Ying Li

Affiliations

Soon will be listed here.

Abstract

Background: Type 2 diabetes (T2D), a widespread chronic metabolic disorder, presents frequently in clinical settings. The relationship between T2D and bone mineral density (BMD) has been subject to ongoing investigation, yielding inconclusive results.

Methods: A systematic literature search was conducted across several databases, including CNKI, VIP, CBM, Wanfang, PubMed, Cochrane Library, and Embase, targeting observational studies that explored the impact of microangiopathy associated with T2D on BMD or bone metabolism. The search spanned from the inception of each database to July 1, 2023. The Newcastle-Ottawa Scale was employed for quality assessment, and RevMan 5.3 software was utilized for data analysis. Stata 14.0 was used for the quantitative evaluation of publication bias regarding outcome measures.

Results: The inclusion criteria were met by 30 observational studies, comprising 6470 participants-3121 with diabetes and 3349 without. The meta-analysis revealed no significant difference in overall BMD between the nondiabetic and T2D groups (mean difference [MD] = -0.07, 95% confidence interval [CI] [-0.17, 0.03], Z = 1.45, P = .15). However, BMD at the lumbar vertebrae was significantly higher in nondiabetic individuals compared with those with T2D (MD = -0.14, 95% CI [-0.22, -0.06], Z = 3.32, P = 0.0009), as was the case with femoral neck BMD (MD = -0.11, 95% CI [-0.18, -0.04], Z = 3.08, P = .002). A difference in femoral neck BMD between nondiabetics and individuals with T2D approached but did not reach statistical significance (MD = -0.14, 95% CI [-0.27, 0.00], Z = 1.94, P = .05). An inverted funnel plot analysis suggested possible publication bias, as evidenced by an asymmetrical distribution of studies around the axis of symmetry, with overlap observed in several cases.

Conclusion: The findings indicate a significant association between T2D and reduced BMD at critical sites such as the lumbar vertebrae and femoral neck, highlighting an increased risk of osteoporosis or osteoporotic fractures in these regions.

References

Zhao Y, Du Y, Gao Y, Xu Z, Zhao D, Yang M . ATF3 Regulates Osteogenic Function by Mediating Osteoblast Ferroptosis in Type 2 Diabetic Osteoporosis. Dis Markers. 2022; 2022:9872243. PMC: 9629949. DOI: 10.1155/2022/9872243. View

Lee H, Hwang J . Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism. Curr Diab Rep. 2020; 20(12):78. DOI: 10.1007/s11892-020-01361-5. View

Rathinavelu S, Guidry-Elizondo C, Banu J . Molecular Modulation of Osteoblasts and Osteoclasts in Type 2 Diabetes. J Diabetes Res. 2018; 2018:6354787. PMC: 6247387. DOI: 10.1155/2018/6354787. View

Wang L, Yu W, Yin X, Cui L, Tang S, Jiang N . Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study. JAMA Netw Open. 2021; 4(8):e2121106. PMC: 8369359. DOI: 10.1001/jamanetworkopen.2021.21106. View

Ratajczak A, Rychter A, Zawada A, Dobrowolska A, Krela-Kazmierczak I . Nutrients in the Prevention of Osteoporosis in Patients with Inflammatory Bowel Diseases. Nutrients. 2020; 12(6). PMC: 7352179. DOI: 10.3390/nu12061702. View

Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R . Diabetes and global ageing among 65-99-year-old adults: Findings from the International Diabetes Federation Diabetes Atlas, 9 edition. Diabetes Res Clin Pract. 2020; 162:108078. DOI: 10.1016/j.diabres.2020.108078. View

Eller-Vainicher C, Cairoli E, Grassi G, Grassi F, Catalano A, Merlotti D . Pathophysiology and Management of Type 2 Diabetes Mellitus Bone Fragility. J Diabetes Res. 2020; 2020:7608964. PMC: 7262667. DOI: 10.1155/2020/7608964. View

Wen Y, Li H, Zhang X, Liu P, Ma J, Zhang L . Correlation of Osteoporosis in Patients With Newly Diagnosed Type 2 Diabetes: A Retrospective Study in Chinese Population. Front Endocrinol (Lausanne). 2021; 12:531904. PMC: 8160464. DOI: 10.3389/fendo.2021.531904. View

Pradhan J, Mishra I, Rattan R, Choudhury A, Baliarsinha A . Correlation of Markers of Inflammation with Hormonal, Metabolic Parameters, Insulin Resistance and Adiposity Indices in First-Degree Relatives of Patient with Polycystic Ovary Syndrome. J Hum Reprod Sci. 2022; 15(3):250-258. PMC: 9635376. DOI: 10.4103/jhrs.jhrs_104_22. View

10.

Kalra S, Joshi A, Kapoor N . Osteoporosis and diabetes: The dual pandemics. J Pak Med Assoc. 2022; 72(8):1663-1664. DOI: 10.47391/JPMA.22-86. View

11.

Vendrami C, Marques-Vidal P, Gonzalez Rodriguez E, Hans D, Waeber G, Lamy O . Thyroid-stimulating hormone is associated with trabecular bone score and 5-year incident fracture risk in euthyroid postmenopausal women: the OsteoLaus cohort. Osteoporos Int. 2021; 33(1):195-204. PMC: 8758596. DOI: 10.1007/s00198-021-06081-4. View

12.

Rios-Arce N, Dagenais A, Feenstra D, Coughlin B, Kang H, Mohr S . Loss of interleukin-10 exacerbates early Type-1 diabetes-induced bone loss. J Cell Physiol. 2019; 235(3):2350-2365. PMC: 6899206. DOI: 10.1002/jcp.29141. View

13.

Bhattoa H, Onyeka U, Kalina E, Balogh A, Paragh G, Antal-Szalmas P . Bone metabolism and the 10-year probability of hip fracture and a major osteoporotic fracture using the country-specific FRAX algorithm in men over 50 years of age with type 2 diabetes mellitus: a case-control study. Clin Rheumatol. 2013; 32(8):1161-7. DOI: 10.1007/s10067-013-2254-y. View

14.

Faienza M, Pontrelli P, Brunetti G . Type 2 diabetes and bone fragility in children and adults. World J Diabetes. 2022; 13(11):900-911. PMC: 9693736. DOI: 10.4239/wjd.v13.i11.900. View

15.

Kalimeri M, Leek F, Wang N, Koh H, Roy N, Cameron-Smith D . Association of Insulin Resistance with Bone Strength and Bone Turnover in Menopausal Chinese-Singaporean Women without Diabetes. Int J Environ Res Public Health. 2018; 15(5). PMC: 5981928. DOI: 10.3390/ijerph15050889. View

16.

Notarnicola A, Maccagnano G, Tafuri S, Moretti L, Laviola L, Moretti B . Epidemiology of diabetes mellitus in the fragility fracture population of a region of Southern Italy. J Biol Regul Homeost Agents. 2016; 30(1):297-302. View

17.

Ma L, Oei L, Jiang L, Estrada K, Chen H, Wang Z . Association between bone mineral density and type 2 diabetes mellitus: a meta-analysis of observational studies. Eur J Epidemiol. 2012; 27(5):319-32. PMC: 3374119. DOI: 10.1007/s10654-012-9674-x. View

18.

Li T, Ling Hu , Yin X, Zou Y, Fu H, Li H . Prevalence and Risk Factors of Osteoporosis in Patients with Type 2 Diabetes Mellitus in Nanchang (China): A Retrospective Cohort Study. Diabetes Metab Syndr Obes. 2022; 15:3039-3048. PMC: 9527700. DOI: 10.2147/DMSO.S372348. View

19.

Welch A, Skinner J, Hickson M . Dietary Magnesium May Be Protective for Aging of Bone and Skeletal Muscle in Middle and Younger Older Age Men and Women: Cross-Sectional Findings from the UK Biobank Cohort. Nutrients. 2017; 9(11). PMC: 5707661. DOI: 10.3390/nu9111189. View

20.

Zhao J, Liang G, Luo M, Yang W, Xu N, Luo M . Influence of type 2 diabetes microangiopathy on bone mineral density and bone metabolism: A meta-analysis. Heliyon. 2022; 8(10):e11001. PMC: 9576898. DOI: 10.1016/j.heliyon.2022.e11001. View